busulfan has been researched along with Arachnoidal Cerebellar Sarcoma, Circumscribed in 11 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We previously demonstrated that Busulfan-Thiotepa (Bu-Thio) and ASCT effectively treated patients with locally relapsed medulloblastoma after surgery and conventional chemotherapy." | 9.11 | High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacy. ( Benhamou, E; Couanet, D; Fillipini, B; Grill, J; Habrand, JL; Hartmann, O; Kalifa, C; Valteau-Couanet, D, 2005) |
| "The aim of the study is to evaluate the outcome of young children with high risk localized medulloblastomas (newly diagnosed classical or incompletely resected) treated by high-dose busulfan-thiotepa with autologous stem cell rescue (ASCT) followed by focal radiation therapy (RT)." | 7.80 | High-dose busulfan-thiotepa with autologous stem cell transplantation followed by posterior fossa irradiation in young children with classical or incompletely resected medulloblastoma. ( Bergthold, G; Dhermain, F; Dufour, C; El Kababri, M; Goma, G; Grill, J; Kieffer, V; Raquin, MA; Sainte-Rose, C; Valteau-Couanet, D; Varlet, P, 2014) |
| "The aim of this in-vitro study was to evaluate the combination of busulfan with radiotherapy on TE-671 human medulloblastoma cells since unexpected clinical toxicity of busulfan was reported during the treatment of brain tumors, suggesting a possible radiopotentiation." | 7.68 | In vitro combination of high dose busulfan with radiotherapy on medulloblastoma cells: additive effect without potentiation. ( Bey, P; Chastagner, P; Marchal, C; Merlin, JL; Weber, B, 1991) |
| "We previously demonstrated that Busulfan-Thiotepa (Bu-Thio) and ASCT effectively treated patients with locally relapsed medulloblastoma after surgery and conventional chemotherapy." | 5.11 | High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacy. ( Benhamou, E; Couanet, D; Fillipini, B; Grill, J; Habrand, JL; Hartmann, O; Kalifa, C; Valteau-Couanet, D, 2005) |
| "The aim of the study is to evaluate the outcome of young children with high risk localized medulloblastomas (newly diagnosed classical or incompletely resected) treated by high-dose busulfan-thiotepa with autologous stem cell rescue (ASCT) followed by focal radiation therapy (RT)." | 3.80 | High-dose busulfan-thiotepa with autologous stem cell transplantation followed by posterior fossa irradiation in young children with classical or incompletely resected medulloblastoma. ( Bergthold, G; Dhermain, F; Dufour, C; El Kababri, M; Goma, G; Grill, J; Kieffer, V; Raquin, MA; Sainte-Rose, C; Valteau-Couanet, D; Varlet, P, 2014) |
| "We evaluated the antitumor activity of busulfan against a panel of tumor cell lines and xenografts in athymic nude mice derived from childhood high-grade glioma, adult high-grade glioma, ependymoma, and medulloblastoma." | 3.69 | Busulfan therapy of central nervous system xenografts in athymic mice. ( Aaron, RH; Bigner, DD; Colvin, OM; Elion, GB; Friedman, HS; Graham, M; Keir, S, 1994) |
| "The aim of this in-vitro study was to evaluate the combination of busulfan with radiotherapy on TE-671 human medulloblastoma cells since unexpected clinical toxicity of busulfan was reported during the treatment of brain tumors, suggesting a possible radiopotentiation." | 3.68 | In vitro combination of high dose busulfan with radiotherapy on medulloblastoma cells: additive effect without potentiation. ( Bey, P; Chastagner, P; Marchal, C; Merlin, JL; Weber, B, 1991) |
| " The highest bioavailability was obtained with busulphan in DMSO administered i." | 1.30 | Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations. ( Boland, I; Gouyette, A; Hartmann, O; Kalifa, C; Morizet, J; Terrier-Lacombe, MJ; Valteau-Couanet, D; Vassal, G, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergthold, G | 1 |
| El Kababri, M | 1 |
| Varlet, P | 1 |
| Dhermain, F | 1 |
| Sainte-Rose, C | 2 |
| Raquin, MA | 2 |
| Kieffer, V | 1 |
| Goma, G | 1 |
| Grill, J | 3 |
| Valteau-Couanet, D | 4 |
| Dufour, C | 1 |
| Nishikawa, T | 1 |
| Okamoto, Y | 1 |
| Tanabe, T | 1 |
| Shinkoda, Y | 1 |
| Kodama, Y | 1 |
| Higashi, M | 1 |
| Hirano, H | 1 |
| Arita, K | 1 |
| Kawano, Y | 1 |
| Pérez-Martínez, A | 1 |
| Lassaletta, A | 1 |
| González-Vicent, M | 1 |
| Sevilla, J | 1 |
| Díaz, MA | 1 |
| Madero, L | 1 |
| Fillipini, B | 1 |
| Benhamou, E | 2 |
| Kalifa, C | 4 |
| Couanet, D | 1 |
| Habrand, JL | 2 |
| Hartmann, O | 3 |
| Ridola, V | 1 |
| Doz, F | 2 |
| Gentet, JC | 1 |
| Frappaz, D | 1 |
| Aaron, RH | 1 |
| Elion, GB | 1 |
| Colvin, OM | 1 |
| Graham, M | 1 |
| Keir, S | 1 |
| Bigner, DD | 1 |
| Friedman, HS | 2 |
| Graham, ML | 1 |
| Herndon, JE | 1 |
| Casey, JR | 1 |
| Chaffee, S | 1 |
| Ciocci, GH | 1 |
| Krischer, JP | 1 |
| Kurtzberg, J | 1 |
| Laughlin, MJ | 1 |
| Longee, DC | 1 |
| Olson, JF | 1 |
| Paleologus, N | 1 |
| Pennington, CN | 1 |
| Dupuis-Girod, S | 1 |
| Mechinaud, F | 1 |
| Bouffet, E | 1 |
| Coze, C | 1 |
| Boland, I | 1 |
| Vassal, G | 1 |
| Morizet, J | 1 |
| Terrier-Lacombe, MJ | 1 |
| Gouyette, A | 1 |
| Foa, C | 1 |
| Magné, N | 1 |
| Bondiau, PY | 1 |
| Otto, J | 1 |
| Thyss, A | 1 |
| Merlin, JL | 1 |
| Chastagner, P | 1 |
| Marchal, C | 1 |
| Weber, B | 1 |
| Bey, P | 1 |
1 review available for busulfan and Arachnoidal Cerebellar Sarcoma, Circumscribed
| Article | Year |
|---|---|
[High-dose chemotherapy in relapse of medulloblastoma in young children].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Cerebellar Ne | 1997 |
2 trials available for busulfan and Arachnoidal Cerebellar Sarcoma, Circumscribed
| Article | Year |
|---|---|
High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cerebel | 2005 |
High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Child, Preschool; Combi | 2005 |
8 other studies available for busulfan and Arachnoidal Cerebellar Sarcoma, Circumscribed
| Article | Year |
|---|---|
High-dose busulfan-thiotepa with autologous stem cell transplantation followed by posterior fossa irradiation in young children with classical or incompletely resected medulloblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cerebellar Neoplasms; Child, Preschool; Co | 2014 |
Unexpectedly high AUC levels in a child who received intravenous busulfan before stem cell transplantation.
Topics: Area Under Curve; Busulfan; Cerebellar Neoplasms; Child; Drug Monitoring; Fatal Outcome; Glutathione | 2010 |
High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Busulfan; Cerebellar Neoplasms; Child | 2007 |
Busulfan therapy of central nervous system xenografts in athymic mice.
Topics: Animals; Brain Neoplasms; Busulfan; Child, Preschool; Cyclophosphamide; Female; Humans; Injections, | 1994 |
High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brai | 1997 |
Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations.
Topics: Administration, Oral; Animals; Biological Availability; Brain Neoplasms; Busulfan; Carboxymethylcell | 1999 |
High-dose chemotherapy with autologous stem cell support in an adult with bone marrow relapse of medulloblastoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Busulfan; Carboplatin; | 2000 |
In vitro combination of high dose busulfan with radiotherapy on medulloblastoma cells: additive effect without potentiation.
Topics: Busulfan; Cell Line; Cerebellar Neoplasms; Colony-Forming Units Assay; Combined Modality Therapy; Hu | 1991 |